Clinical trial NCT05238987 - References

Insulin Secretion — Effect of Taking a Single Tablet of Iron on Insulin Secretion

Citation(s)

•   Abraham D, Rogers J, Gault P, Kushner JP, McClain DA
  Increased insulin secretory capacity but decreased insulin sensitivity after correction of iron overload by phlebotomy in hereditary haemochromatosis. Diabetologia. 2006 Nov;49(11):2546-51. Epub 2006 Sep 22.
•   Auerbach M, Adamson JW
  How we diagnose and treat iron deficiency anemia. Am J Hematol. 2016 Jan;91(1):31-8. doi: 10.1002/ajh.24201. Epub 2015 Nov 17. Review.
•   Backe MB, Moen IW, Ellervik C, Hansen JB, Mandrup-Poulsen T
  Iron Regulation of Pancreatic Beta-Cell Functions and Oxidative Stress. Annu Rev Nutr. 2016 Jul 17;36:241-73. doi: 10.1146/annurev-nutr-071715-050939. Epub 2016 May 4. Review.
•   Blesia V, Patel VB, Al-Obaidi H, Renshaw D, Zariwala MG
  Excessive Iron Induces Oxidative Stress Promoting Cellular Perturbations and Insulin Secretory Dysfunction in MIN6 Beta Cells. Cells. 2021 May 9;10(5). pii: 1141. doi: 10.3390/cells10051141.
•   Brissot P, Ropert M, Le Lan C, Loréal O
  Non-transferrin bound iron: a key role in iron overload and iron toxicity. Biochim Biophys Acta. 2012 Mar;1820(3):403-10. doi: 10.1016/j.bbagen.2011.07.014. Epub 2011 Aug 9. Review.
•   Castillo MJ, Scheen AJ, Letiexhe MR, Lefèbvre PJ
  How to measure insulin clearance. Diabetes Metab Rev. 1994 Jul;10(2):119-50. Review.
•   Coffey R, Knutson MD
  The plasma membrane metal-ion transporter ZIP14 contributes to nontransferrin-bound iron uptake by human ß-cells. Am J Physiol Cell Physiol. 2017 Feb 1;312(2):C169-C175. doi: 10.1152/ajpcell.00116.2016. Epub 2016 Nov 30.
•   Cooksey RC, Jones D, Gabrielsen S, Huang J, Simcox JA, Luo B, Soesanto Y, Rienhoff H, Abel ED, McClain DA
  Dietary iron restriction or iron chelation protects from diabetes and loss of beta-cell function in the obese (ob/ob lep-/-) mouse. Am J Physiol Endocrinol Metab. 2010 Jun;298(6):E1236-43. doi: 10.1152/ajpendo.00022.2010. Epub 2010 Mar 30.
•   Dresow B, Petersen D, Fischer R, Nielsen P
  Non-transferrin-bound iron in plasma following administration of oral iron drugs. Biometals. 2008 Jun;21(3):273-6. Epub 2007 Sep 13.
•   Farmaki K, Angelopoulos N, Anagnostopoulos G, Gotsis E, Rombopoulos G, Tolis G
  Effect of enhanced iron chelation therapy on glucose metabolism in patients with beta-thalassaemia major. Br J Haematol. 2006 Aug;134(4):438-44. Epub 2006 Jul 4.
•   Fuqua BK, Vulpe CD, Anderson GJ
  Intestinal iron absorption. J Trace Elem Med Biol. 2012 Jun;26(2-3):115-9. doi: 10.1016/j.jtemb.2012.03.015. Epub 2012 May 8. Review.
•   Geisser P, Burckhardt S
  The pharmacokinetics and pharmacodynamics of iron preparations. Pharmaceutics. 2011 Jan 4;3(1):12-33. doi: 10.3390/pharmaceutics3010012.
•   Goddard AF, James MW, McIntyre AS, Scott BB; British Society of Gastroenterology
  Guidelines for the management of iron deficiency anaemia. Gut. 2011 Oct;60(10):1309-16. doi: 10.1136/gut.2010.228874. Epub 2011 May 11.
•   Hansen JB, Tonnesen MF, Madsen AN, Hagedorn PH, Friberg J, Grunnet LG, Heller RS, Nielsen AØ, Størling J, Baeyens L, Anker-Kitai L, Qvortrup K, Bouwens L, Efrat S, Aalund M, Andrews NC, Billestrup N, Karlsen AE, Holst B, Pociot F, Mandrup-Poulsen T
  Divalent metal transporter 1 regulates iron-mediated ROS and pancreatic ß cell fate in response to cytokines. Cell Metab. 2012 Oct 3;16(4):449-61. doi: 10.1016/j.cmet.2012.09.001. Epub 2012 Sep 20.
•   Jenkitkasemwong S, Wang CY, Coffey R, Zhang W, Chan A, Biel T, Kim JS, Hojyo S, Fukada T, Knutson MD
  SLC39A14 Is Required for the Development of Hepatocellular Iron Overload in Murine Models of Hereditary Hemochromatosis. Cell Metab. 2015 Jul 7;22(1):138-50. doi: 10.1016/j.cmet.2015.05.002. Epub 2015 May 28.
•   Kapil U, Kapil R, Gupta A
  National Iron Plus Initiative: Current status & future strategy. Indian J Med Res. 2019 Sep;150(3):239-247. doi: 10.4103/ijmr.IJMR_1782_18. Review.
•   Matsuda M, DeFronzo RA
  Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999 Sep;22(9):1462-70.
•   McClain DA, Abraham D, Rogers J, Brady R, Gault P, Ajioka R, Kushner JP
  High prevalence of abnormal glucose homeostasis secondary to decreased insulin secretion in individuals with hereditary haemochromatosis. Diabetologia. 2006 Jul;49(7):1661-9. Epub 2006 Mar 15.
•   Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J
  Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004 Dec 17;306(5704):2090-3. Epub 2004 Oct 28.
•   Solomon TPJ
  Sources of Inter-individual Variability in the Therapeutic Response of Blood Glucose Control to Exercise in Type 2 Diabetes: Going Beyond Exercise Dose. Front Physiol. 2018 Jul 13;9:896. doi: 10.3389/fphys.2018.00896. eCollection 2018. Review.
•   Van Cauter E, Mestrez F, Sturis J, Polonsky KS
  Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes. 1992 Mar;41(3):368-77.

Acute Effect of a Single Dose of Oral Iron on Pancreatic Beta Cell Function in Healthy Individuals: a Quasi-experimental Single Arm Before-and-after (Pre-post) Study

Details for clinical trial NCT05238987